Monkeypox: a 10% Fatality Rate and Now Spreading in DRC
The world is facing a new health threat: Clade I Monkeypox virus (MPXV). This variant of the Mpox virus has a 10% fatality rate and is now spreading in the Democratic Republic of the Congo (DRC). While cases related to this subtype have not been reported in the United States, healthcare professionals and public health officials should be aware of the symptoms of Monkeypox and be especially wary of travelers from the DRC who may be carrying the virus.
The disease usually begins with a fever, swollen lymph nodes, fatigue, and a severe headache. Within a few days, a rash begins to appear on the face and other parts of the body and can eventually lead to the formation of a bump or a blister. In addition, there may also be lesions and ulcers on areas of the body other than the face and chest. In some cases, the disease can be fatal, causing pneumonia, meningitis, high fever, and breathing difficulties.
Monkeypox can be easily spread from person-to-person through contact such as through blood, saliva, and other bodily fluids. It can also be transferred when contact is made with an animal that has the virus. In most cases, individuals infected with the virus will recover without any complications. However, people with weak immune systems may be more likely to experience severe symptoms.
Public health officials are highly concerned about the spread of the virus in the DRC. The country is facing an increase in cases due to its lack of public health infrastructure and its weak economy. In addition, the DRC has also experienced recent outbreaks of other infectious diseases such as Ebola and polio. The spread of Monkeypox needs to be addressed quickly and efficiently to prevent it from becoming a more widespread issue.
In addition to the DRC, there are also cases of Monkeypox reported in other countries including Nigeria, Ghana, and the Central African Republic. While the virus is not highly contagious, medical experts are recommending travelers to take extra precaution if they are planning to visit any of these countries.
Fortunately, Monkeypox can be easily treated with antiviral drugs such as vaccinia immune globulin, cidofovir, and ribavirin. For those who display mild symptoms, rest and hydration are usually enough to treat the infection. Symptoms will usually go away within two to four weeks, but severe cases can last up to six months.
Public health officials are also recommending that individuals in the DRC get vaccinated. This will help to stop the spread of the virus to neighboring countries. In addition, individuals should take extra precautions when traveling to prevent the spread of the disease.
In conclusion, the spread of Clade I Monkeypox virus is a serious health issue that needs to be addressed, especially in countries with weaker public health infrastructure such as the DRC. We should all be informed and take precautionary measures to prevent the further spread of the virus. With the right measures in place, we can ensure that Monkeypox does not become a global health crisis.
